Good news for the needle-nervous: research supports the safety of this approach
Spontaneous reporting systems alone cannot definitively determine whether a medication causes a specific adverse event
At any given time, about 90% of the hairs on your head are in the anagen phase
We are encouraged by the results of TRIUMPH-4, which highlight the powerful effect of retatrutide, a first-in-class triple agonist, on body weight, pain and physical function
[3] Maquart FX, Bellon G, Pasco S, Monboisse JC
The ratiometric FRET signal takes account of differences in the number of internalized receptors, and is indicative of avidity of binding